| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,397 | 157,581 | 158,917 | 158,697 | | Cost of Revenue | 26,970 | 30,890 | 37,073 | 41,514 | | | Gross Profit |
-
| 126,691 | 121,844 | 117,183 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,430 | 55,168 | 48,521 | 42,181 | | Non Recurring | (32,791) | 37,447 | 200 | 8,795 | | Others | 162,022 | 154,166 | 80,885 | 45,876 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (120,090) | (7,762) | 20,331 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (96,234) | (120,090) | (7,762) | 20,331 | | Interest Expense | 25,074 | 27,183 | 28,169 | 31,539 | | Income Before Tax | (121,308) | (147,273) | (35,931) | (11,208) | | Income Tax Expense | (52,777) | (60,548) | (13,465) | (13,574) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (68,531) | (86,725) | (22,466) | 2,366 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| (5,366) |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (68,531) | (92,091) | (22,466) | 2,366 | | Preferred Stock And Other Adjustments | (10,620) | (23,623) | (8,743) | (5,385) | | | Net Income Applicable To Common Shares | ($79,151) | ($115,714) | ($31,209) | ($3,019) |
|
0.20% Nasdaq 
Income Statement
